These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 34125445)

  • 21. Immune checkpoint molecules are regulated by transforming growth factor (TGF)-
    Shrestha R; Bridle KR; Crawford DHG; Jayachandran A
    Int J Med Sci; 2021; 18(12):2466-2479. PubMed ID: 34104078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune checkpoint molecules B7-H6 and PD-L1 co-pattern the tumor inflammatory microenvironment in human breast cancer.
    Cherif B; Triki H; Charfi S; Bouzidi L; Kridis WB; Khanfir A; Chaabane K; Sellami-Boudawara T; Rebai A
    Sci Rep; 2021 Apr; 11(1):7550. PubMed ID: 33824367
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance and correlation of PD-L1, B7-H3, B7-H4, and TILs in pancreatic cancer.
    Yang J; Tian Z; Gao H; Xiong F; Cao C; Yu J; Shi W; Zhan Q; Yang C
    BMC Cancer; 2022 May; 22(1):584. PubMed ID: 35624419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inter- and intra-tumor heterogeneity of metastatic prostate cancer determined by digital spatial gene expression profiling.
    Brady L; Kriner M; Coleman I; Morrissey C; Roudier M; True LD; Gulati R; Plymate SR; Zhou Z; Birditt B; Meredith R; Geiss G; Hoang M; Beechem J; Nelson PS
    Nat Commun; 2021 Mar; 12(1):1426. PubMed ID: 33658518
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression and clinical significance of B7-H3 and miR-145 in lung cancer patients with malignant pleural effusion.
    Huang L
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6759-6766. PubMed ID: 32633367
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of B7-H3 expression on tumour-infiltrating immune cells and clinicopathological characteristics in non-small-cell lung cancer.
    Yim J; Koh J; Kim S; Song SG; Ahn HK; Kim YA; Jeon YK; Chung DH
    Eur J Cancer; 2020 Jul; 133():74-85. PubMed ID: 32447027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PD-L1 promoter methylation is a prognostic biomarker for biochemical recurrence-free survival in prostate cancer patients following radical prostatectomy.
    Gevensleben H; Holmes EE; Goltz D; Dietrich J; Sailer V; Ellinger J; Dietrich D; Kristiansen G
    Oncotarget; 2016 Nov; 7(48):79943-79955. PubMed ID: 27835597
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-expressed B7-H3 mediates the inhibition of antitumor T-cell functions in ovarian cancer insensitive to PD-1 blockade therapy.
    Cai D; Li J; Liu D; Hong S; Qiao Q; Sun Q; Li P; Lyu N; Sun T; Xie S; Guo L; Ni L; Jin L; Dong C
    Cell Mol Immunol; 2020 Mar; 17(3):227-236. PubMed ID: 31611650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor and immune cell PD-L1 expression in bladder tumors predicts disease recurrence and survival.
    Toren P; Brisson H; Simonyan D; Hovington H; Lacombe L; Bergeron A; Fradet Y
    World J Urol; 2021 May; 39(5):1549-1558. PubMed ID: 32676741
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7-H3 and B7x are highly expressed in human prostate cancer and associated with disease spread and poor outcome.
    Zang X; Thompson RH; Al-Ahmadie HA; Serio AM; Reuter VE; Eastham JA; Scardino PT; Sharma P; Allison JP
    Proc Natl Acad Sci U S A; 2007 Dec; 104(49):19458-63. PubMed ID: 18042703
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PD-L1 Expression and CD8
    Petitprez F; Fossati N; Vano Y; Freschi M; Becht E; Lucianò R; Calderaro J; Guédet T; Lacroix L; Rancoita PMV; Montorsi F; Fridman WH; Sautès-Fridman C; Briganti A; Doglioni C; Bellone M
    Eur Urol Focus; 2019 Mar; 5(2):192-196. PubMed ID: 28753812
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Genetic and clinical characterization of B7-H3 (CD276) expression and epigenetic regulation in diffuse brain glioma.
    Wang Z; Wang Z; Zhang C; Liu X; Li G; Liu S; Sun L; Liang J; Hu H; Liu Y; Zhang W; Jiang T
    Cancer Sci; 2018 Sep; 109(9):2697-2705. PubMed ID: 30027617
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B7-H3 Promotes Prostate Cancer Progression in Mice by Antagonizing Myeloid-Derived Suppressor Cell Apoptosis.
    Zhou Y; Zhang G; Zhang W; Wei X; Hou J; Huang Y
    Technol Cancer Res Treat; 2020; 19():1533033820971649. PubMed ID: 33280506
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting Radiation-Resistant Prostate Cancer Stem Cells by B7-H3 CAR T Cells.
    Zhang Y; He L; Sadagopan A; Ma T; Dotti G; Wang Y; Zheng H; Gao X; Wang D; DeLeo AB; Fan S; Sun R; Yu L; Zhang L; Wang G; Ferrone S; Wang X
    Mol Cancer Ther; 2021 Mar; 20(3):577-588. PubMed ID: 33653946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. B7-H3 Negatively Modulates CTL-Mediated Cancer Immunity.
    Yonesaka K; Haratani K; Takamura S; Sakai H; Kato R; Takegawa N; Takahama T; Tanaka K; Hayashi H; Takeda M; Kato S; Maenishi O; Sakai K; Chiba Y; Okabe T; Kudo K; Hasegawa Y; Kaneda H; Yamato M; Hirotani K; Miyazawa M; Nishio K; Nakagawa K
    Clin Cancer Res; 2018 Jun; 24(11):2653-2664. PubMed ID: 29530936
    [No Abstract]   [Full Text] [Related]  

  • 36. B7-H4 Immune Checkpoint Protein Affects Viability and Targeted Therapy of Renal Cancer Cells.
    Emaldi M; Nunes-Xavier CE
    Cells; 2022 Apr; 11(9):. PubMed ID: 35563753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrated analysis reveals distinct molecular, clinical, and immunological features of B7-H3 in acute myeloid leukemia.
    Zhang LY; Jin Y; Xia PH; Lin J; Ma JC; Li T; Liu ZQ; Xiang HL; Cheng C; Xu ZJ; Zhou H; Qian J
    Cancer Med; 2021 Nov; 10(21):7831-7846. PubMed ID: 34562306
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression and clinical significance of PD-L1, B7-H3, B7-H4 and TILs in human small cell lung Cancer (SCLC).
    Carvajal-Hausdorf D; Altan M; Velcheti V; Gettinger SN; Herbst RS; Rimm DL; Schalper KA
    J Immunother Cancer; 2019 Mar; 7(1):65. PubMed ID: 30850021
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis.
    Qin X; Sun W; Wang C; Li M; Zhao X; Li C; Zhang H
    Reprod Biol Endocrinol; 2021 Jul; 19(1):114. PubMed ID: 34289871
    [TBL] [Abstract][Full Text] [Related]  

  • 40. B7-H3 expression in upper tract urothelial carcinoma associates with adverse clinicopathological features and poor survival.
    Koyama Y; Morikawa T; Miyama Y; Miyakawa J; Kawai T; Kume H; Sawabe M; Ushiku T
    Pathol Res Pract; 2020 Dec; 216(12):153219. PubMed ID: 33049447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.